Case - Female Sexual Dysfunction: Does Surgically Induced Menopause Matter?

	Unregistered User Click here if this is not your Personal Edition
		Contact Us \| Free E-Mail Updates \| Journals \| Register a colleague

Menopause

EXPLORE :

Most Read News

All Webcasts / CME

Warning | Privacy

Recent cases - Menopause

	Giant Ovarian Serous Cystadenoma in a Postmenopausal Woman: A Case Report
	Spontaneous Perforated Pyometra with an Intrauterine Device in Menopause: a Case Report
	Female Sexual Dysfunction
	A Postmenopausal Woman Presenting with Atypical Symptoms and Cervical Cancer : A Case Report

Recent news - Menopause

	TopAbstracts in Menopause 12/08/2009 - (DGNews)
	FDA Approves Low-Dose Local Oestrogen Therapy for the Treatment of Atrophic Vaginitis Due to Menopause - (DGNews)
	TopAbstracts in Menopause 11/24/2009 - (DGNews)
	TopAbstracts in Menopause 11/10/2009 - (DGNews)
	TopAbstracts in Menopause 10/27/2009 - (DGNews)

Recent webcasts/CME - Menopause

	Issues in Postmenopausal Hormone Therapy
	The Council on Menopause Management Video: Clinical Challenges and Quality of Life Issues
	How to Appropriately Counsel and Manage a Recently Menopausal Woman Worried About the Safety of Hormone Therapy
	Endocrinology and Management of Hormone Therapy in Older Women
	Endocrinology and Management of Hormone Therapy in Older Women

personal edition > menopause > cases

Cases

E-Mail this case to a colleague

Female Sexual Dysfunction: Does Surgically Induced Menopause Matter?

Presented by:	Baylor College of Medicine / James A. Simon, MD, CCD, FACOG
Summary points:	A 47-year-old with 1-year history of hysterectomy and oophorectomy presents with hot flashes, night sweats, and vaginal dryness that partially responded to oral conjugated equine oestrogens. This case report describes the clinical presentation, treatments, and outcome. The authors discuss the symptoms of hypoactive sexual desire disorder in women with surgically induced menopause, potential contributory factors, effects of different forms of oestrogen, and the impact of testosterone supplementation.
Accreditation:	Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Baylor College of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Expiration date: March 2010.
Other:

Additional Information